CLINICAL_TRIALS
trial_result
· 2022-08-30
Clinical Trial Update: RETHINC: REdefining THerapy In Early COPD for the Pulmonary Trials Cooperative [Phase 3]
Summary
Phase 3 trial update for REdefining THerapy In Early COPD (RETHINC) completed; results posted in 2022.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Michigan | Conditions: COPD (Chronic Obstructive Pulmonary Disease) | Phase 3 | Status: COMPLETED | Results posted: 2022-08-30